Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APYX Apyx Medical	$2.12 -9.8%	$2.07	$0.76 ▼ $2.73	$80.18M	1.39	116,124 shs	146,235 shs
IRIX IRIDEX	$1.12 -5.1%	$1.10	$0.78 ▼ $2.14	$18.81M	0.62	90,114 shs	178,566 shs
NTRB Nutriband	$6.30 -5.4%	$7.87	$3.72 ▼ $11.78	$70.27M	1.13	146,066 shs	68,938 shs
VANI Vivani Medical	$1.27 +0.8%	$1.34	$0.91 ▼ $1.80	$75.24M	2.99	108,522 shs	61,992 shs

10 Stocks Set to Soar in Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APYX Apyx Medical	+4.91%	+15.20%	+19.29%	+58.78%	+113.64%
IRIX IRIDEX	-9.23%	-9.23%	+15.69%	+18.00%	-40.10%
NTRB Nutriband	-2.06%	-4.17%	-17.16%	+18.93%	+13.65%
VANI Vivani Medical	-0.79%	-9.35%	-15.44%	+22.33%	+8.62%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
APYX Apyx Medical	1.7609 of 5 stars	0.0	3.0	4.2	2.4	1.7	0.6
IRIX IRIDEX	0.9194 of 5 stars	0.0	4.0	0.0	2.8	1.7	0.0
NTRB Nutriband	3.2412 of 5 stars	3.5	5.0	0.0	2.3	1.7	0.6
VANI Vivani Medical	3.0873 of 5 stars	3.5	3.0	0.0	3.3	3.3	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APYX Apyx Medical	2.67	Moderate Buy	N/A	N/A
IRIX IRIDEX	0.00	N/A	N/A	N/A
NTRB Nutriband	3.00	Buy	$13.00	108.17% Upside
VANI Vivani Medical	3.00	Buy	$4.00	216.21% Upside

Current Analyst Ratings Breakdown

Latest IRIX, APYX, VANI, and NTRB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/19/2025	VANI Vivani Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$4.00 ➝ $4.00

(Data available from 8/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APYX Apyx Medical	$46.51M	1.74	N/A	N/A	$0.20 per share	10.68
IRIX IRIDEX	$48.67M	0.39	N/A	N/A	$0.13 per share	8.81
NTRB Nutriband	$2.40M	29.04	N/A	N/A	$0.58 per share	10.77
VANI Vivani Medical	N/A	N/A	N/A	N/A	$0.30 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APYX Apyx Medical	-$23.46M	-$0.45	N/A	N/A	N/A	-37.11%	-158.22%	-28.30%	N/A
IRIX IRIDEX	-$8.91M	-$0.43	N/A	∞	N/A	-10.95%	-293.27%	-17.47%	N/A
NTRB Nutriband	-$10.48M	-$0.90	N/A	N/A	N/A	-415.93%	-68.25%	-60.40%	9/2/2025 (Estimated)
VANI Vivani Medical	-$23.49M	-$0.45	N/A	N/A	N/A	N/A	-133.07%	-56.50%	N/A

Latest IRIX, APYX, VANI, and NTRB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/2/2025	N/A	NTRB Nutriband	-$0.17	N/A	N/A	N/A	$0.71 million	N/A
8/13/2025	Q2 2025	VANI Vivani Medical	-$0.10	-$0.12	-$0.02	-$0.12	N/A	N/A
8/12/2025	Q2 2025	IRIX IRIDEX	-$0.09	-$0.06	+$0.03	-$0.06	$13.10 million	$13.57 million
8/7/2025	Q2 2025	APYX Apyx Medical	-$0.0933	-$0.09	+$0.0033	-$0.09	$11.69 million	$11.37 million
5/30/2025	Q1 2026	NTRB Nutriband	-$0.13	-$0.12	+$0.01	-$0.12	$0.71 million	$0.67 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
APYX Apyx Medical	N/A	N/A	N/A	N/A	N/A
IRIX IRIDEX	N/A	N/A	N/A	N/A	N/A
NTRB Nutriband	N/A	N/A	N/A	N/A	N/A
VANI Vivani Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APYX Apyx Medical	4.61	4.72	3.95
IRIX IRIDEX	4.28	1.95	1.27
NTRB Nutriband	0.01	3.71	3.48
VANI Vivani Medical	N/A	2.40	2.40

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
APYX Apyx Medical	55.33%
IRIX IRIDEX	20.10%
NTRB Nutriband	19.70%
VANI Vivani Medical	6.78%

Insider Ownership

Company	Insider Ownership
APYX Apyx Medical	15.20%
IRIX IRIDEX	7.40%
NTRB Nutriband	54.09%
VANI Vivani Medical	46.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
APYX Apyx Medical	270	37.82 million	32.07 million	Optionable
IRIX IRIDEX	120	16.79 million	15.55 million	Optionable
NTRB Nutriband	10	11.15 million	5.12 million	Not Optionable
VANI Vivani Medical	20	59.24 million	31.76 million	Optionable

IRIX, APYX, VANI, and NTRB Headlines

Recent News About These Companies

Vivani closes $10M financing, advances GLP-1 implant

5 hours ago | drugdeliverybusiness.comD

Vivani Medical, Inc.: Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

August 14 at 8:14 AM | finanznachrichten.de

Vivani Medical (NASDAQ:VANI) Stock Price Down 0.8% Following Weak Earnings

August 14 at 2:41 AM | americanbankingnews.com

Vivani Medical Reports Q2 2025 Results and $10M Financing

August 13 at 12:38 AM | tipranks.com

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second ...

August 13 at 9:47 PM | bakersfield.comB

Vivani Medical Secures $10M Through Share Purchase Agreement

August 13 at 9:47 PM | msn.com

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

August 13 at 4:20 PM | globenewswire.com

Vivani Medical (VANI) to Release Quarterly Earnings on Tuesday

August 6, 2025 | marketbeat.com

Vivani Medical, Inc. (NASDAQ:VANI) Sees Large Growth in Short Interest

August 2, 2025 | marketbeat.com

Vivani Medical (NASDAQ:VANI) Shares Up 0.6% - Here's What Happened

July 23, 2025 | marketbeat.com

3 Penny Stocks With Market Caps Over $30M To Consider

July 16, 2025 | finance.yahoo.com

Vivani Medical Insiders Added US$5.29m Of Stock To Their Holdings

June 30, 2025 | uk.finance.yahoo.com

Vivani Medical shareholders elect board and approve key proposals at annual meeting - Investing.com

June 27, 2025 | investing.com

Vivani Medical Appoints Anthony Baldor as Chief Financial Officer

June 11, 2025 | manilatimes.netM

Vivani Medical to Present at the 2025 BIO International Convention

June 11, 2025 | finance.yahoo.com

Vivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit

June 2, 2025 | zacks.com

Companies To Watch: Vivani Medical

May 30, 2025 | lifescienceleader.comL

Vivani files with SEC to spin off neurostim business, focus on drug delivery implants

May 29, 2025 | massdevice.com

Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders

May 29, 2025 | finance.yahoo.com

Vivani Medical Reports Q1 2025 Results and Strategic Updates

May 19, 2025 | tipranks.com

Vivani Medical, Inc.: Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

May 15, 2025 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRIX, APYX, VANI, and NTRB Company Descriptions

Apyx Medical NASDAQ:APYX

$2.12 -0.23 (-9.79%)

Closing price 04:00 PM Eastern

Extended Trading

$2.12 +0.00 (+0.24%)

As of 05:13 PM Eastern

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

IRIDEX NASDAQ:IRIX

$1.14 -0.04 (-2.97%)

As of 04:00 PM Eastern

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Nutriband NASDAQ:NTRB

$6.30 -0.36 (-5.41%)

Closing price 04:00 PM Eastern

Extended Trading

$6.40 +0.09 (+1.51%)

As of 05:33 PM Eastern

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Vivani Medical NASDAQ:VANI

$1.27 +0.01 (+0.79%)

Closing price 04:00 PM Eastern

Extended Trading

$1.26 -0.01 (-0.39%)

As of 05:19 PM Eastern

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time